FDA Modernization Act promises to spare animals, bring safer and better treatments to patients, and drive down drug prices.
The U.S. Congress passed the FDA Modernization Act 2.0 as part of the Omnibus Bill, Sec. 3209. This means drug development’s primitive and non-human-relevant process will no longer be required for market approval.
A historic milestone in the acceptance of alternatives to animal models in drug discovery. Alternatives that capture human physiology better, that are more ethical, sustainable and most importantly can accelerate the discovery of life changing therapies.
Learn how 3D bioprinting can replace animal models in drug discovery: